Используйте голову, чтобы спасти мозг. Профилактика деменции в любом возрасте - Клионски Митчелл

Okereke OI, Reynolds CF, Mischoulon D, et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. J Am Med Assoc. 2020;324(5):471–480. doi: 10.1001/jama.2020.10224

Paillusson S, Stoica R, Gómez-Suaga P, et al. There’s something wrong with my MAM: the ER – mitochondria axis and neurodegenerative diseases. Trends Neurosci. 2016;39(3):146–157. doi: 10.1016/j.tins.2016.01.008 For Further Reading 243

Pilling LC, Jones LC, Masoli JAH, et al. Low vitamin D levels and risk of incident delirium in 351,000 older UK Biobank participants. J Am Geriatr Soc. 2021;69(2):365–372. doi: 10.1111/jgs.16853. Epub 2020 Oct 5.

Prins ND, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology. 2002;59(9):1375–1380. doi: 10.1212/01.WNL.0000032494.05619.93

Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636–643. doi: 10.1093/ajcn/82.3.636

Regland B, McCaddon A. Alzheimer’s amyloidopathy: an alternative aspect. J Alzheimers Dis. 2019;68(2):483–488. doi: 10.3233/JAD-181007

Rodgers GP, Collins FS. Precision nutrition: the answer to “what to eat to stay healthy.” J Am Med Assoc. 2020;324(8):735–736. doi: 10.1001/jama.2020.13601

Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J. ER stress in Alzheimer’s disease: a novel neuronal trigger for inflammation and Alzheimer’s pathology. J Neuroinflammation. 2009:41. doi: 10.1186/1742-2094-6-41

Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Eng J Med. 2002;346(7):476–483. doi: 10.1056/NEJMoa011613

Slinin Y, Paudel ML, Taylor BC, et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010;74(1):33–41. doi: 10.1212/wnl.0b013e3181c7197b

Smith AD, Refsum H, Bottiglieri T, et al. Homocysteine and dementia: an international consensus statement. J Alzheimers Dis. 2018;62(2):561–570. doi: 10.3233/JAD-171042

Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010. doi: 10.1371/journal.pone.0012244

Spedding S. Vitamins are more funky than Casimir thought. Australas Med J. 2013;6(2):104–106. doi: 10.4066/AMJ.2013.1588

Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLOS Medicine, 2004;1,e62. doi: 10.1371/journal.pmed.0010062

Tezapsidis N, Johnston JM, Smith MA, et al. Leptin: a novel therapeutic strategy 244 For Further Reading for Alzheimer’s disease. J Alzheimers Dis. 2009;16(4):731–740. doi: 10.3233/jad-2009-1021

Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A III. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82(3):627–635. doi: 10.1093/ajcn.82.3.627

Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4–S8. doi: 10.2215/CJN.01490506

Xu W, Tan L, Wang HF, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299–1306. doi: 10.1136/jnnp-2015-310548. Epub 2015 Aug 20.

Yassine HN, Braskie MN, Mack WJ, et al. Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: a review. JAMA Neurol. 2017;74(3):339–347. doi: 10.1001/jamaneurol.2016.4899

Zhao C, Tsapanou A, Manly J, Schupf, N, Brickman AM, Gu, Y. Vitamin D intake is associated with dementia risk in the Washington Heights – Inwood Columbia Aging Project (WHICAP). Alzheimers Dement. 2020;16:1393–1401. doi: 10.1002/alz.12096

Alexander CM, Seifert HA, Blouin RT, Conrad PF, Gross JB. Diphenhydramine enhances the interaction of hypercapnic and hypoxic ventilatory drive. Anesthesiology. 1994;80:789–795.

Boeuf-Cazou O, Bongue B, Ansiau D, Marquie J-C, Lapeyre-Mestre M. Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur J Clin Pharmacol. 2011;67:1045. doi: 10.1007/s00228-011-1047-y

Campbell NL, Holden R, Boustani MA. Preventing Alzheimer disease by deprescribing anticholinergic medications. JAMA Intern Med. 2019;179(8):1093–1094. doi: 10.1001/jamainternmed.2019.0676

Cohen PA, Avula B, Wang YH, Zakharevich I, Khan I. Five unapproved drugs found in cognitive enhancement supplements. Neurol Clin Pract. 2021;11(3):e303–e307. doi: 10.1212/CPJ.0000000000000960

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control For Further Reading 245 study. JAMA Intern Med. 2019;179(8):1084–1093. doi: 10.1001/jamaintern

Crowe S, Stranks E. The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol. 2018;33:901–911. doi: 10.1093/arclin/acx120

D’Amico G, deFranchis R, Dell’Era A, eds. National history and stages of cirrhosis and variceal hemorrhage. Springer Science+Business Media; 2014. doi: 10.1007/978-1-4939-0002-2_2

Esser MB, Sherk A, Liu Y, et al. Deaths and years of potential life lost from excessive alcohol use – United States, 2011–2015. Morbidity and Mortality Weekly Report. 2020;69:981–987. doi: 10.15585/mmwr.mm6930a1

Flippo TS, Holder WD. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch Surg. 1993;128(12):1391–1395. doi: 10.1001/archsurg.1993.01420240099018

Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–407. doi: 10.1001/jamainternmed.2014.7663

Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986;49:341–345.

He Q, Chen X, Wu T, Li L, Fei X. Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies. J Clin Neurol. 2019;15(1):9–19. doi: 10.3988/jcn.2019.15.1.9. Epub 2018 Oct 26.

Islam MM, Iqbal U, Walther B, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47:181–191. doi: 10.1159/000454881

Kim JW, Lee DY, Lee BC, et al. Alcohol and cognition in the elderly: a review. Psychiatry Investig. 2012;9:8–16. doi: 10.4306/pi.2012.9.1.8

Kivimäki M, Singh-Manoux A, Batty GD, et al. Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open. 2020;3(9):e2016084. doi: 10.1001/jamanetworkopen.2020.16084

National Institute on Alcohol Abuse and Alcoholism. Alcohol facts and statistics. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/alcohol-facts-and-statistics

Oscar-Berman M, Marinkovic K. Alcoholism and the brain: an overview. Alcohol Res Health. 2003;27(2):125–133.

Paterniti S, Dufouil C, Alpérovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the epidemiology of vascular aging study. J Clin Psychopharmacol. 2002;22(3):285–293.

Raphael KC, Matuja SS, Shen NT, Liwa AC, Jaka H. Hepatic encephalopathy; prevalence, precipitating factors and challenges of management in a resource-limited setting. J Gastrointest Digest Syst. 2016;6(3):441. doi: 10.4172/2161-069X.1000441